Evidence map›Paper›PMID 33941677›Full record

Trial reportProceedings of the National Academy of Sciences of the United States of America2021

Manipulating placebo analgesia and nocebo hyperalgesia by changing brain excitability.

Yiheng Tu, Georgia Wilson, Joan Camprodon, Darin D Dougherty, Mark Vangel, Fabrizio Benedetti, Ted J Kaptchuk, Randy L Gollub, Jian Kong

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Proceedings of the National Academy of Sciences of the United States of America, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 2 pooled it
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 2 syntheses or guidelines pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Effects of prefrontal transcranial direct current stimulation on open-label placebo responses.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  10. Article
  11. A review of descending pain modulation in humans.Frontiers in pain research (Lausanne, Switzerland) · 2026
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. The Nocebo Effect.Annual review of pharmacology and toxicology · 2024
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Yiheng TuDepartment of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129.ORCID 0000-0002-3495-9549
Georgia WilsonDepartment of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129.
Joan CamprodonDepartment of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129.
Darin D DoughertyDepartment of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129.ORCID 0000-0003-4691-4353
Mark VangelDepartment of Radiology, Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129.
Fabrizio BenedettiDepartment of Neuroscience, University of Turin Medical School, Turin I-10126, Italy.
Ted J KaptchukProgram in Placebo Studies, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215.ORCID 0000-0002-2253-1940
Randy L GollubDepartment of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129.ORCID 0000-0002-9434-4044
Jian KongDepartment of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129; kongj@nmr.mgh.harvard.edu.
Harvard University · USBeth Israel Deaconess Medical Center · USSanthera Pharmaceuticals (Switzerland) · CH

Funding

Neuromodulation of placebo and nocebo effectsR01AT008563 · NCCIH · MASSACHUSETTS GENERAL HOSPITAL · PI KONG, JIAN · 2015 to 2019
$3.9M
NCCIH NIH HHS R01 AT008563
6 · The paper itself

Abstract

Harnessing placebo and nocebo effects has significant implications for research and medical practice. Placebo analgesia and nocebo hyperalgesia, the most well-studied placebo and nocebo effects, are thought to initiate from the dorsal lateral prefrontal cortex (DLPFC) and then trigger the brain's descending pain modulatory system and other pain regulation pathways. Combining repeated transcranial direct current stimulation (tDCS), an expectancy manipulation model, and functional MRI, we investigated the modulatory effects of anodal and cathodal tDCS at the right DLPFC on placebo analgesia and nocebo hyperalgesia using a randomized, double-blind and sham-controlled design. We found that compared with sham tDCS, active tDCS could 1) boost placebo and blunt nocebo effects and 2) modulate brain activity and connectivity associated with placebo analgesia and nocebo hyperalgesia. These results provide a basis for mechanistic manipulation of placebo and nocebo effects and may lead to improved clinical outcomes in medical practice.

Indexed as

AdultAnalgesiaAnalysis of VarianceBrainDouble-Blind MethodFemaleHumansHyperalgesiaMagnetic Resonance ImagingMaleNocebo EffectPainPain ManagementPlacebo EffectPrefrontal CortexSurveys and Questionnairesdorsolateral prefrontal cortexexpectancy manipulationmechanistic manipulationplacebo and nocebo effectstranscranial direct current stimulation

Identifiers

PMID33941677
PMCPMC8126770
OpenAlexW3158536159

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.